ANTIMICROBIAL RESISTANCE IN THE UNITED STATES, THE EUROPEAN UNION, AND CANADA: A COMPARATIVE ANALYSIS OF POLICY APPROACHES AND PROMISING SOLUTIONS
Antimicrobial resistance (AMR) is becoming a major global burden on both low-middle- and high-income countries. Recent projections claim that the cumulative loss in economic output in OECD countries will total between $20 and $35 trillion by 2050 (O’Neill, 2014). An estimate by the World Bank Group (2017) suggests that, in the worst-case scenario, the global Gross domestic Product (GDP) growth fall due to AMR could be comparable to the 2008-2009 financial crisis.
Display your AMR Technology, Product and Service
Suppliers and Users of Technologies, Products and Services benefit from CAPI.
CAPI (Continuous AMR Partnering Initiative) unites Suppliers and Users worldwide with the aim to add to the curbing of AMR.